Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CBA Florida, Inc.CBAI · Entity 148644 | Co-Chief Executive Officer · 10% owner | June 04, 2020 | June 08, 2020 |
| CRYO CELL INTERNATIONAL INCCCEL · Entity 7400 | Director · Chairman, Co-CEO · 10% owner | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CBA Florida, Inc.
Report date June 04, 2020 · Filed June 08, 2020
Jointly reported with CRYO CELL INTERNATIONAL INC, Portnoy Mark L.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663,572 |
Reported balance
After 2020-06-04 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2020-06-04 · Sale · Disposed 530,000 · Balance 4,663,572 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 3,433,483 |
Reported balance
After 2020-06-05 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2020-06-05 · Sale · Disposed 1,230,089 · Balance 3,433,483 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 114,207,446 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 114,207,446 F1: Shares owned solely by Cryo-Cell International, Inc. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 5,614,932 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,614,932 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 4,061,770 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,061,770 F3: Shares owned solely by Mark L. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares owned solely by Cryo-Cell International, Inc.
F2: Shares owned solely by David I. Portnoy.
F3: Shares owned solely by Mark L. Portnoy.
F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
CRYO CELL INTERNATIONAL INC
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 247,438 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Other · Disposed 600,191 · Balance 247,438 F1: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy David Portnoy Irrevocable 2026 Trust Agreement | 600,191 |
Reported balance
After 2026-08-05 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-05 · Other · Acquired 600,191 · Balance 600,191 F1: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Corporation | 161,833 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 161,833 F2: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. |
| Common StockSEC Table I · non-derivative | IndirectBy Corporation | 57,306 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 57,306 F3: Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary. |
| Common StockSEC Table I · non-derivative | IndirectBy 401K | 164,182 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 164,182 |
| Common StockSEC Table I · non-derivative | IndirectBy IRA | 268,878 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 268,878 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 107,403 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 107,403 |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 59,027 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 59,027 F4: Shares of common stock held by Mayim Limited Partnership, as to which David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership. |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for son | 12,214 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 12,214 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for son | 11,804 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 11,804 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for son | 11,212 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 11,212 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.53 · Expires 2029-08-30 | Direct | 26,243 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 26,243 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.28 · Expires 2029-12-20 | Direct | 23,636 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 23,636 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.27 · Expires 2028-12-22 | Direct | 280,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 280,000 F5: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.77 · Expires 2028-01-03 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 50,000 F6: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.30 · Expires 2027-12-23 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 50,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.47 · Expires 2028-12-22 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 50,000 F7: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.08 · Expires 2030-01-21 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 50,000 F8: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.89 · Expires 2031-01-07 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 50,000 F9: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.89 · Expires 2031-01-07 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 150,000 F10: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein.
F2: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
F3: Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
F4: Shares of common stock held by Mayim Limited Partnership, as to which David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
F5: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
F6: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
F7: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
F8: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
F9: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
F10: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 9,491 | $4.80 | $45,556.80 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 11 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 229,571 Read SEC document |
| November 15, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 6,000 | $4.81 | $28,860.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 6 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 804,742 Read SEC document |
| November 15, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 10,000 | $4.80 | $48,000.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 810,742 Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 10,000 | $4.80 | $48,000.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 10 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 220,080 Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 10,000 | $4.80 | $48,000.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,742 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 3,000 | $4.80 | $14,400.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 9 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 210,080 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 3,000 | $4.77 | $14,310.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 8 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 207,080 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 3,000 | $4.81 | $14,430.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 830,742 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 3,495 | $4.77 | $16,671.15 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,742 Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 22:20 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 3,000 | $4.79 | $14,370.00 |
DisclosureSEC source: 0001209191-22-057065 · doc4.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,237 Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherCommon Stock | 9,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 13 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · As Custodian for Son Disclosed balance after: 0 F3 · timeliness: Transferred shares to son's account as he is now of age. Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 3,850 | $4.90 | $18,865.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 8 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 117,012 Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherCommon Stock | 9,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 6 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · As Custodian for Daughter Disclosed balance after: 0 F1 · timeliness: Transferred shares to daughter's account since she is now of age. Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 5 | $5.00 | $25.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,237 Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 1,500 | $4.90 | $7,350.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,242 Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 4,000 | $4.91 | $19,640.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 841,742 Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 5,000 | $4.88 | $24,400.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 9 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 204,080 Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 15,000 | $4.90 | $73,500.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 7 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 113,162 Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 10,000 | $5.01 | $50,100.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 845,742 Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 22:28 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | SaleCommon Stock | 5,000 | $5.05 | $25,250.00 |
DisclosureSEC source: 0001209191-22-056434 · doc4.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855,742 Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 70,270 | $3.14 Strike: $3.14 | $220,647.80 |
DisclosureSEC source: 0001209191-22-047883 · doc4.xml · derivative · entry 14 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,270 shares Expires 2026-04-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 70,270 | $3.14 | $220,647.80 |
DisclosureSEC source: 0001209191-22-047883 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 280,000 | $12.27 Strike: $12.27 | $3,435,600.00 |
DisclosureSEC source: 0001209191-22-024406 · doc4a.xml · derivative · entry 23 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2028-12-22 F5 · kind: The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting. F7 · derivative.exercise_date: Stock options vest immediately when the price of the Company's stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| April 08, 2022 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 553 | $12.27 Strike: $12.27 | $6,785.31 |
DisclosureSEC source: 0001209191-22-024406 · doc4a.xml · derivative · entry 22 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553 Underlying: Common Stock · 553 shares Expires 2024-12-22 F5 · kind: The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting. F6 · derivative.exercise_date: One-third of the stock options will vest on December 22, 2022, one-third will vest on January 22, 2023 and one-third on January 22, 2024. Read SEC document |
| April 08, 2022 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 24,447 | $13.50 Strike: $13.50 | $330,034.50 |
DisclosureSEC source: 0001209191-22-024406 · doc4a.xml · derivative · entry 21 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,447 Underlying: Common Stock · 24,447 shares Expires 2024-12-22 F5 · kind: The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting. F6 · derivative.exercise_date: One-third of the stock options will vest on December 22, 2022, one-third will vest on January 22, 2023 and one-third on January 22, 2024. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 280,000 | $12.27 Strike: $12.27 | $3,435,600.00 |
DisclosureSEC source: 0001209191-21-071278 · doc4.xml · derivative · entry 19 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2028-12-22 F5 · derivative.exercise_date: Stock options vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| December 22, 2021 Filed Dec 27, 2021 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 25,000 | $12.27 Strike: $12.27 | $306,750.00 |
DisclosureSEC source: 0001209191-21-071278 · doc4.xml · derivative · entry 18 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-12-22 F4 · derivative.exercise_date: Stock options fully vest upon issuance. Read SEC document |
| December 22, 2021 Filed Feb 8, 2022 22:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 280,000 | $12.27 Strike: $12.27 | $3,435,600.00 |
DisclosureSEC source: 0001209191-22-007782 · doc4a.xml · derivative · entry 20 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2028-12-22 F6 · shares: Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term. Read SEC document |
| December 22, 2021 Filed Feb 8, 2022 22:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 553 | $12.27 Strike: $12.27 | $6,785.31 |
DisclosureSEC source: 0001209191-22-007782 · doc4a.xml · derivative · entry 19 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553 Underlying: Common Stock · 553 shares Expires 2024-12-22 F5 · shares: The reporting person is amending his Form 4 filed on December 27, 2021 to correct an inadvertent error in reporting the exercise price of the Incentive Stock Option due to the reporting person being a 10% shareholder. This amended Form 4 also breaks out the stock option grant for Incentive Stock Options versus Non-Qualified Stock Options due to the value restrictions on Incentive Stock Options. The vesting is 1/3 on the date of grant, 1/3 on December 22, 2022 and 1/3 on December 22, 2023. Read SEC document |
| December 22, 2021 Filed Feb 8, 2022 22:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 24,447 | $13.50 Strike: $13.50 | $330,034.50 |
DisclosureSEC source: 0001209191-22-007782 · doc4a.xml · derivative · entry 18 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,447 Underlying: Common Stock · 24,447 shares Expires 2024-12-22 F5 · shares: The reporting person is amending his Form 4 filed on December 27, 2021 to correct an inadvertent error in reporting the exercise price of the Incentive Stock Option due to the reporting person being a 10% shareholder. This amended Form 4 also breaks out the stock option grant for Incentive Stock Options versus Non-Qualified Stock Options due to the value restrictions on Incentive Stock Options. The vesting is 1/3 on the date of grant, 1/3 on December 22, 2022 and 1/3 on December 22, 2023. Read SEC document |
| December 22, 2021 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Disposition to issuerStock Option · Derivative | 280,000 | $12.27 Strike: $12.27 | $3,435,600.00 |
DisclosureSEC source: 0001209191-22-024406 · doc4a.xml · derivative · entry 20 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 280,000 shares Expires 2028-12-22 F4 · kind: On April 8, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. Read SEC document |
| December 22, 2021 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Disposition to issuerStock Option · Derivative | 553 | $12.27 Strike: $12.27 | $6,785.31 |
DisclosureSEC source: 0001209191-22-024406 · doc4a.xml · derivative · entry 19 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 553 shares Expires 2024-12-22 F4 · kind: On April 8, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. Read SEC document |
| December 22, 2021 Filed Apr 14, 2022 20:00 UTC Amendment | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Disposition to issuerStock Option · Derivative | 24,447 | $13.50 Strike: $13.50 | $330,034.50 |
DisclosureSEC source: 0001209191-22-024406 · doc4a.xml · derivative · entry 18 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,447 shares Expires 2024-12-22 F4 · kind: On April 8, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 67,816 | $2.90 Strike: $2.90 | $196,666.40 |
DisclosureSEC source: 0001209191-21-053500 · doc4.xml · derivative · entry 15 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,816 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Tax withholdingCommon Stock | 25,500 | $10.50 | $267,750.00 |
DisclosureSEC source: 0001209191-21-053500 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 790,472 F1 · shares: Shares of common stock were withheld by the Company as payment for the exercise price of the common stock and associated tax liabilities. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 67,816 | $2.90 | $196,666.40 |
DisclosureSEC source: 0001209191-21-053500 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2021 Filed Jul 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 158 | $9.45 | $1,493.10 |
DisclosureSEC source: 0001209191-21-048202 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Corporation Disclosed balance after: 152,882 F1 · ownership.nature: Shares of Common Stock held by Mayim Investment Limited Partnership as is David I. Portnoy my be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 21:05 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 100 | $9.24 | $923.50 |
DisclosureSEC source: 0001209191-21-047409 · doc4.xml · nonDerivative · entry 10 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Indirect · As Custodian for Son Disclosed balance after: 11,352 Read SEC document |
| May 27, 2021 Filed May 27, 2021 21:51 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 946 | $8.65 | $8,182.90 |
DisclosureSEC source: 0001209191-21-036311 · doc4.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 98,162 Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 32,184 | $2.90 Strike: $2.90 | $93,333.60 |
DisclosureSEC source: 0001209191-21-035964 · doc4.xml · derivative · entry 16 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,816 Underlying: Common Stock · 32,184 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionStock Option · Derivative | 200,000 | $1.72 Strike: $1.72 | $344,000.00 |
DisclosureSEC source: 0001209191-21-035964 · doc4.xml · derivative · entry 15 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 32,184 | $2.90 | $93,333.60 |
DisclosureSEC source: 0001209191-21-035964 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | Exercise / conversionCommon Stock | 200,000 | $1.72 | $344,000.00 |
DisclosureSEC source: 0001209191-21-035964 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 25, 2021 21:02 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 1,000 | $8.46 | $8,460.00 |
DisclosureSEC source: 0001209191-21-035737 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,972 Read SEC document |
| May 13, 2021 Filed May 19, 2021 01:37 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 2,000 | $8.55 | $17,100.00 |
DisclosureSEC source: 0001209191-21-033857 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,972 Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 1,000 | $8.85 | $8,850.00 |
DisclosureSEC source: 0001209191-21-032094 · doc4.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,972 Read SEC document |
| May 12, 2021 Filed May 12, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 100 | $8.42 | $842.00 |
DisclosureSEC source: 0001209191-21-032094 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,972 Read SEC document |
| May 11, 2021 Filed May 12, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 100 | $8.58 | $858.00 |
DisclosureSEC source: 0001209191-21-032094 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,872 Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 457 | $8.45 | $3,861.65 |
DisclosureSEC source: 0001209191-21-032094 · doc4.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401K Disclosed balance after: 97,216 Read SEC document |
| May 03, 2021 Filed May 5, 2021 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 459 | $8.45 | $3,878.55 |
DisclosureSEC source: 0001209191-21-030364 · doc4.xml · nonDerivative · entry 11 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO 10b5-1 filing: Not disclosed Ownership: Indirect · As Custodian for Son Disclosed balance after: 11,242 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.